VIR-2218 plus VIR-3434 combination therapy reduces hepatitis B virus surface antigen levels in vivo

Noack, J; Gall, J; Imam, H; Anglero-Rodriguez, Y; Jadhav, V; Schmid, MA; Bakardjiev, A; Purcell, LA; Hebner, C; Lempp, F

JOURNAL OF HEPATOLOGY, 2022; 77 (): S871